(19)
(11)
EP 0 840 787 A2
(12)
(43)
Date of publication:
13.05.1998
Bulletin 1998/20
(21)
Application number:
96945463.0
(22)
Date of filing:
20.06.1996
(51)
International Patent Classification (IPC):
G01N
33/
53
( . )
A61K
45/
00
( . )
A61P
29/
00
( . )
C07K
16/
28
( . )
C12N
1/
21
( . )
C12N
15/
09
( . )
C12P
21/
02
( . )
G01N
33/
566
( . )
A61K
38/
00
( . )
A61K
48/
00
( . )
C07K
14/
705
( . )
C12N
1/
19
( . )
C12N
5/
10
( . )
C12N
15/
12
( . )
C12P
21/
08
( . )
(86)
International application number:
PCT/US1996/010618
(87)
International publication number:
WO 1997/000952
(
09.01.1997
Gazette 1997/03)
(84)
Designated Contracting States:
BE DE ES FR GB IT NL
(30)
Priority:
20.06.1995
US 19950000352P
06.12.1995
US 19950567817
(71)
Applicant:
INCYTE PHARMACEUTICALS, INC.
Palo Alto , CA 94304 (US)
(72)
Inventor:
SEILHAMER, Jeffrey J.
Los Altos Hills, CA 94022 (US)
(74)
Representative:
Wright, Simon Mark
J.A. Kemp & Co. 14 South Square Gray's Inn
London WC1R 5LX
London WC1R 5LX (GB)
(54)
A HUMAN EDG-2 RECEPTOR HOMOLOG